CeO 2 -Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals

This study is one of the first attempts to assess CeO nanoparticles as a nanoplatform for radiopharmaceuticals with radionuclides. The process of functionalization using a bifunctional azacrown ligand is described, and the resulting conjugates are characterized by IR and Raman spectroscopy. Their co...

Full description

Saved in:
Bibliographic Details
Published in:Nanomaterials (Basel, Switzerland) Switzerland), 2022-12, Vol.12 (24)
Main Authors: Khabirova, Sofia, Aleshin, Gleb, Plakhova, Tatiana, Zubenko, Anastasia, Shchukina, Anna, Fedorova, Olga, Averin, Aleksey, Belova, Ekaterina, Bazarkina, Elena, Kvashnina, Kristina, Kalmykov, Stepan
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study is one of the first attempts to assess CeO nanoparticles as a nanoplatform for radiopharmaceuticals with radionuclides. The process of functionalization using a bifunctional azacrown ligand is described, and the resulting conjugates are characterized by IR and Raman spectroscopy. Their complexes with Bi show a high stability in medically relevant media, thus encouraging the further study of these conjugates in vivo as potential combined radiopharmaceuticals.
ISSN:2079-4991
2079-4991